MedPath

Fentanyl Citrate, Bupivacaine HCl

Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 250 mL Bag

Approved
Approval ID

cfecc5f4-5ce0-46d5-b1d4-92654246fcb2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 13, 2014

Manufacturers
FDA

Cantrell Drug Company

DUNS: 035545763

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fentanyl Citrate, Bupivacaine HCl

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52533-080
Product Classification
G
Generic Name
Fentanyl Citrate, Bupivacaine HCl
Product Specifications
Route of AdministrationEPIDURAL
Effective DateAugust 11, 2014
FDA Product Classification

INGREDIENTS (6)

BUPIVACAINE HYDROCHLORIDEActive
Quantity: 1.25 mg in 1 mL
Code: 7TQO7W3VT8
Classification: ACTIR
Sodium ChlorideInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT
Fentanyl CitrateActive
Quantity: 2 ug in 1 mL
Code: MUN5LYG46H
Classification: ACTIM
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: CNTM
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: CNTM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fentanyl Citrate, Bupivacaine HCl - FDA Drug Approval Details